Clinical Trial Update: Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating N-acetylcysteine for Bipolar Disorder has completed; results were posted on 2024-06-26.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Bipolar Ii Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Bipolar Disorder, Bipolar I Disorder | Phase 2 | Status: COMPLETED | Results posted: 2024-06-26